| Jul 30 |
Top 3 Health Care Stocks You May Want To Dump This Quarter
|
| Jul 30 |
Verona Pharma to Present at 44th Annual Canaccord Growth Conference
|
| Jul 25 |
Verona Pharma to Report Second Quarter 2024 Financial Results and Provide Corporate Update
|
| Jul 12 |
Verona (VRNA) Stock Surges 36% in the Past Month: Here's Why
|
| Jun 30 |
Verona Pharma Is Launching Ohtuvayre, Although There Will Be Competition
|
| Jun 27 |
Verona scores FDA approval for Ohtuvayre as COPD maintenance therapy
|
| Jun 27 |
First Inhaled COPD Therapy In Over 2 Decades - FDA Approves Verona Pharma's First Commercial Product
|
| Jun 27 |
FDA go-ahead for Verona Ohtuvayre transforms US COPD exacerbator market
|
| Jun 26 |
Verona wins FDA approval of ensifentrine for COPD; stock surges 20%
|
| Jun 26 |
Verona Pharma Announces US FDA Approval of Ohtuvayre™ (ensifentrine)
|
